Concepedia

Paul Collini

PC

26

Publications

3.4K

Citations

21

H-Index

2006

Active since

Affiliations

University of Sheffield(Current)

University of Nottingham

University of Edinburgh

University of Oxford

Sheffield Teaching Hospitals NHS Foundation Trust

Paul Collini is an author at University of Sheffield specializing in medicine, covid-19, and viral immunity.

ORCID

Top concepts

Publications per year

2006–2024

26

Publications

26

Azithromycin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

Eugenia Abaleke, Mustafa Abbas, Sadia Abbasi et al. · The Lancet · 2021 · 555 citations · Full text

, , +7

Convalescent plasma in patients admitted to hospital with COVID-19 (RECOVERY): a randomised controlled, open-label, platform trial

Obbina Abani, Ali Abbas, Fatima Abbas et al. · The Lancet · 2021 · 516 citations · Full text

Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

Obbina Abani, Ali Abbas, Fatima Abbas et al. · The Lancet · 2022 · 382 citations · Full text

, , +3

D614G Spike Mutation Increases SARS CoV-2 Susceptibility to Neutralization

Drew Weissman, Mohamad‐Gabriel Alameh, Thushan I. de Silva et al. · Cell Host & Microbe · 2020 · 351 citations · Full text

, , +6

Aspirin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

Obbina Abani, Ali Abbas, Fatima Abbas et al. · The Lancet · 2021 · 289 citations · Full text

Rows per page

1–5 of 26